Monthly prophylactic garadacimab significantly reduces hereditary angioedema attacks
1. Compared to placebo, monthly garadacimab significantly reduced the number of hereditary angioedema attacks per month. 2. Overall, garadacimab was ...
Tag: C1-inhibitor deficiency
#VisualAbstract: Donidalorsen reduces attacks in patients with hereditary angioedema
1. Patients with hereditary angioedema receiving donidalorsen showed reduced rates of angioedema attacks compared to patients receiving placebo treatment. 2. ...
Donidalorsen reduces attacks in patients with C1 inhibitor deficiency
1. Patients with hereditary angioedema receiving donidalorsen showed reduced rates of angioedema attacks compared to patients receiving placebo treatment. 2. ...
Garadacimab significantly reduces frequency of hereditary angioedema exacerbations
1. Garadacimab significantly reduced the number of monthly attacks in patients with hereditary angioedema compared to placebo. 2. No serious ...
